PALVATA Trademark

Trademark Overview


On Wednesday, March 9, 2011, a trademark application was filed for PALVATA with the United States Patent and Trademark Office. The USPTO has given the PALVATA trademark a serial number of 85262092. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 9, 2021. This trademark is owned by Biovail Laboratories International SRL. The PALVATA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations and substances for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations and products for use in dermatology; antifungal preparations; pharmaceutical preparations and substances for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations and products for ophthalmological use; pharmaceutical preparations and substances for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; ...
palvata

General Information


Serial Number85262092
Word MarkPALVATA
Filing DateWednesday, March 9, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 9, 2021
Registration Number4647300
Registration DateTuesday, December 2, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 16, 2014

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations and substances for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations and products for use in dermatology; antifungal preparations; pharmaceutical preparations and substances for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations and products for ophthalmological use; pharmaceutical preparations and substances for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations and substances for use in chemotherapy; Pharmaceutical preparations and substances for use in urology; pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, anti-inflammatories and pain relief medication; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances for the treatment of fungal infections, onychomycosis, tinea infections, and similar diseases of the skin and nails; pharmaceutical preparations and substances for use in dermatological conditions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBAUSCH HEALTH IRELAND LIMITED
Party Type33 - New Owner After Registration
Legal Entity Type99 - Other
AddressDUBLIN 24
IE

Party NameVALEANT PHARMACEUTICALS IRELAND LIMITED
Party Type32 - New Owner After Registration
Legal Entity Type99 - Other
AddressDUBLIN 24
IE

Party NameVALEANT PHARMACEUTICALS LUXEMBOURG S.À.R.L
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressLUXEMBOURG CITY 1931
LU

Party NameVALEANT INTERNATIONAL (BARBADOS) SRL
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCHRIST CHURCH BB17154
BB

Party NameVALEANT INTERNATIONAL (BARBADOS) SRL
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCHRIST CHURCH BB17154
BB

Party NameVALEANT INTERNATIONAL (BARBADOS) SRL
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressCHRIST CHURCH BB17154
BB

Party NameBiovail Laboratories International SRL
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressChrist Church BB17154
BB

Trademark Events


Event DateEvent Description
Friday, July 9, 2021CANCELLED SEC. 8 (6-YR)
Monday, December 2, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 10, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 20, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 16, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 16, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 21, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, January 11, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, March 3, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 21, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, December 2, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, September 16, 2014PUBLISHED FOR OPPOSITION
Wednesday, August 27, 2014NOTICE OF PUBLICATION
Friday, August 8, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, August 4, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 20, 2014FINAL REFUSAL MAILED
Wednesday, February 19, 2014FINAL REFUSAL WRITTEN
Thursday, January 30, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 29, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 29, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 22, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 22, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 31, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 31, 2013NON-FINAL ACTION E-MAILED
Wednesday, July 31, 2013NON-FINAL ACTION WRITTEN
Thursday, July 11, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 11, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 11, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 16, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 16, 2013NON-FINAL ACTION E-MAILED
Wednesday, January 16, 2013NON-FINAL ACTION WRITTEN
Monday, January 7, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 7, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 7, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, August 1, 2012ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, July 6, 2012NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, July 6, 2012INQUIRY TO SUSPENSION E-MAILED
Friday, July 6, 2012SUSPENSION INQUIRY WRITTEN
Tuesday, July 3, 2012LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, June 27, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 26, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 26, 2012TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, June 27, 2012ASSIGNED TO LIE
Thursday, December 15, 2011NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, December 15, 2011LETTER OF SUSPENSION E-MAILED
Thursday, December 15, 2011SUSPENSION LETTER WRITTEN
Thursday, December 15, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 15, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 15, 2011ASSIGNED TO LIE
Friday, December 9, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 9, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 9, 2011NON-FINAL ACTION E-MAILED
Thursday, June 9, 2011NON-FINAL ACTION WRITTEN
Thursday, June 9, 2011ASSIGNED TO EXAMINER
Wednesday, April 6, 2011AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, March 14, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 12, 2011NEW APPLICATION ENTERED IN TRAM